INTRODUCTION
Thrombasthenia is an inherited bleeding disorder (1) characterized by the failure of platelets to aggregate after various stimuli such as ADP (2, 3) . This disorder is transmitted as a recessive autosomal trait. Presumed heterozygous individuals have neither abnormal bleeding tendencies nor defective platelet aggregation. Various abnormalities have been described in this disease (4) , and one report suggests that there Received for publication 23 January 1975 and in revised form 24 March 1975. is an unusual pattern of membrane platelet glycoprotein (5) .
We have had the opportunity of studying the serum of a thrombasthenic patient which reacts with all normal platelets tested but not with thrombasthenic platelets. This report deals with the characterization of the antigen involved and with family studies showing a defect in healthy heterozygous individuals.
METHODS
Patient L had the classical features of thrombasthenia and suffered mainly from intestinal bleeding. Diagnosis was established by prolonged bleeding time, impaired clot retraction, and the complete failure of platelets to aggregate either spontaneously or after incubation with ADP. No other coagulation defects were found, and the number and morphology of the platelets were normal. At the time of the study the patient had received no transfusions for 2 yr, but 9 X 1010 of his sister's platelets were infused to study their survival and to determine the efficiency of platelet transfusion before major surgery. The sample of serum L under study was obtained 15 days after this infusion.
Platelets were obtained by differential centrifugation at 40C of blood taken into plastic tubes on disodium EDTA at a final concentration of 0.5%. They were washed three times and stored at 40C at a concentration of 2 X 106/hl in plain saline containing 0.1% sodium azide.
Qualitative complement fixation (6 (9) . The volume of eluate obtained was 1.5 ml.
Inhibition of platelet aggregation. Aggregation was estimated using Born's photometric method (10 Indirect ininnotoprecipitation of soluble antigens (13) .
The labeling of platelet surfaces with iodine-125 by the lactoperoxidase method was performed as previously described by Marchalonis (14) . one, four, and eight complement units were fixed on days 0, 2, and 4, respectively. A plateau was reached on day 4 and remained stable for more than 6 mo. Platelets from the eight thrombasthenic patients showed a total lack of reactivity no matter what their age (Fig. 1) .
Similar studies were performed in three different thrombasthenic families. The complement fixation curves for the presumably heterozygous relations of patient L (both parents and one child) showed a reactivity pattern midway between that of the patient and that of normal individuals (Fig. 1) . In a second family two children were affected. The two parents and a sibling had intermediate patterns, whereas another sibling was normal. In a third family, only the patient's mother was tested. She also showed an intermediate pattern. All thrombasthenic platelets reacted normally in the complement fixation test with anti-HL-A antibodies.
The direct complement fixation test could detect the antigenic determinant on solubilized membrane antigens. Soluble antigens were obtained from whole platelets or from crude membranes either by spontaneous release or by chaotropic agents. The antigenic yield was measured by its C fixing activity. The highest yield (25,000 U of fixing activity for 20 X 109 platelets) was obtained using lithium chloride. When potassium chloride or spontaneous release were used, the yield was 12,500 U and 5,000 U, respectively, for the same number of platelets. Using serum or eluate L, indirect specific immunoprecipitation of soluble antigens labeled with iodine-125, extracted by the detergent Nonidet P-40 and electrophoresis on sodium dodecyl sulfate polyacrylamide gel, showed a single radioactive peak accounting for 1% of the total antigens labeled, thus corresponding to a molecule of 120,000+5,000 (Fig. 2) . The control, using normal serum, gave no peak.
ADP-induced aggregation of normal platelets was completely inhibited by eluate L up to a dilution of 1: 20. Thrombin, collagen, and epinephrine also inhibited aggregation but ristocetin did not.
DISCUSSION
The antiplatelet antibodies found in a polytransfused thrombasthenic patient were clearly different from the usual complement fixing platelet antibodies which are directed against HL-A or ABO antigens or, more rarely, against Pl' or Pin' (9) . A previous report (17) of shortened survival of ABO and HL-A matched platelets in another thrombasthenic patient may have suggested the existence of a similar antibody, but this could not be proved by in vitro experiments. The antibodies found in serum L recognized an antigenic determinant present on normal human, mouse, and dog platelets but clearly absent from those of other thrombasthenic patients.
A quantitative study of platelets from families afflicted with thrombasthenia indicated an intermediate amount of antigen in the parents and children of patients. Although this is an autosomal recessive disease, on clinical grounds the ability to distinguish between normal and heterozygous individuals in a thrombasthenic family may be of practical importance in spite of the low gene frequency of the thrombasthenic trait.
These findings strongly suggest that the antigenic determinant absent from thrombasthenic patients is born by a molecule involved in platelet aggregation. This hypothesis is supported by the fact that APDinduced aggregation of normal platelets is inhibited by eluate L.
Isolated human platelet membranes have previously been shown to contain a heterogenous group of polypeptides of different classes of molecular weight ranging from 10,000 to 250,000 (18) (19) (20) . Only a few of these membrane proteins have as yet been isolated, and their functional properties are still unknown.
The molecular weight of the molecule bearing the antigenic determinant under study was estimated by two different methods (Sephadex G-200 filtration of soluble membrane extracts and electrophoresis in sodium dodecyl sulfate polyacrylamide gel). It averages 120,000. Inasmuch as a 10% acrylamide gel was used, the molecular weight estimation would not be inaccurate even if the antigen is a glycoprotein (21) . This protein seems clearly to be different from the protein of 80,000 daltons (thrombosthenin) studied by Nachman and Ferris (22) . Nurden and Caen's work (5) suggest that one of the three maj or glycoproteins in normal platelet extracts was missing from the platelets of three thrombasthenic patients. The molecular weight of this protein was approximately 135,000.
Our data demonstrate that thrombasthenic patients have a molecular defect. It cannot be shown whether the gene products are indeed absent or merely nonfunctional, and further studies involving purification of the component from normal platelets are required to characterize its properties more fully.
